Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 5.72B | 6.79B | 6.53B | 4.74B | 3.57B |
Gross Profit | 1.28B | 1.65B | 1.53B | 1.24B | 883.11M |
EBITDA | 1.01B | 1.48B | 1.09B | 1.20B | 776.48M |
Net Income | 278.88M | 647.73M | 737.69M | 650.91M | 296.82M |
Balance Sheet | |||||
Total Assets | 10.07B | 11.06B | 9.20B | 6.13B | 5.61B |
Cash, Cash Equivalents and Short-Term Investments | 75.97M | 126.50M | 127.02M | 68.91M | 81.62M |
Total Debt | 4.26B | 4.64B | 3.58B | 1.62B | 1.66B |
Total Liabilities | 5.61B | 6.37B | 5.31B | 2.79B | 2.66B |
Stockholders Equity | 4.38B | 4.61B | 3.81B | 3.28B | 2.89B |
Cash Flow | |||||
Free Cash Flow | 506.81M | 342.26M | 420.94M | 430.02M | 340.73M |
Operating Cash Flow | 839.29M | 899.26M | 813.74M | 704.42M | 624.65M |
Investing Cash Flow | -498.90M | -1.68B | -2.42B | -490.26M | -310.63M |
Financing Cash Flow | -399.56M | 876.29M | 1.68B | -221.36M | -306.99M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $6.58B | 9.38 | 23.47% | 2.23% | 3.82% | ― | |
77 Outperform | $8.63B | 14.16 | 16.31% | 2.39% | -6.88% | -4.93% | |
72 Outperform | $5.99B | 19.39 | 9.15% | ― | 1.48% | 9.36% | |
71 Outperform | $5.83B | 34.75 | 3.79% | ― | -6.23% | -71.35% | |
68 Neutral | $2.79B | 12.00 | 8.59% | 0.19% | -0.24% | 26.74% | |
68 Neutral | $8.07B | 22.88 | 20.26% | 2.49% | -2.49% | -65.96% | |
61 Neutral | HK$21.05B | 12.25 | 0.81% | 4.52% | 2.72% | -47.45% |
On July 7, 2025, Darling Ingredients Inc. amended and restated its Bylaws to update procedural requirements for stockholders to take action without a meeting. This change is aimed at streamlining governance processes, potentially impacting the company’s operational efficiency and stakeholder engagement.
The most recent analyst rating on (DAR) stock is a Buy with a $69.00 price target. To see the full list of analyst forecasts on Darling Ingredients stock, see the DAR Stock Forecast page.
On June 24, 2025, Darling Global Finance B.V., a subsidiary of Darling Ingredients Inc., issued €750 million in senior notes due 2032, with a 4.5% interest rate. This issuance, alongside a new credit agreement, refinanced existing debt, extended maturities, and redeemed €515 million of senior notes due 2026. The refinancing aims to optimize Darling’s financial structure, potentially enhancing its market position and operational flexibility.
The most recent analyst rating on (DAR) stock is a Buy with a $69.00 price target. To see the full list of analyst forecasts on Darling Ingredients stock, see the DAR Stock Forecast page.
On June 18, 2025, Darling Ingredients Inc. announced the pricing of a €750 million offering of 4.5% senior notes due 2032 by its subsidiary, Darling Global Finance B.V. The proceeds will be used to redeem existing senior notes and repay some of the company’s debt, allowing Darling to maintain its debt cost while extending the term of the notes. The offering is expected to close around June 24, 2025, subject to customary conditions, and is part of Darling’s strategy to optimize its financial structure.
The most recent analyst rating on (DAR) stock is a Buy with a $69.00 price target. To see the full list of analyst forecasts on Darling Ingredients stock, see the DAR Stock Forecast page.
On June 16, 2025, Darling Ingredients Inc. announced that its subsidiary, Darling Global Finance B.V., launched an offering of €750 million in senior notes, subject to market conditions. The company also plans to amend its credit agreement to a Third Amended and Restated Credit Agreement. The proceeds from the notes will be used to redeem existing senior notes and repay certain credit facilities, reflecting Darling’s strategic financial restructuring efforts.
The most recent analyst rating on (DAR) stock is a Buy with a $69.00 price target. To see the full list of analyst forecasts on Darling Ingredients stock, see the DAR Stock Forecast page.
On May 12, 2025, Darling Ingredients Inc. announced a non-binding term sheet with Tessenderlo Group to form a joint venture, Nextida, combining their collagen and gelatin businesses. Darling will hold an 85% stake, and Tessenderlo 15%. This strategic partnership aims to create a leading company in the collagen-based health, wellness, and nutrition sectors, with expected annual revenue of $1.5 billion. The venture is anticipated to close in 2026, subject to customary conditions and regulatory approvals, and is expected to enhance product development and shareholder value while expanding market reach.
At the annual meeting held on May 7, 2025, Darling Ingredients Inc. stockholders elected the Board of Directors and voted on two proposals. The proposals included ratifying KPMG LLP as the independent registered public accountant for the fiscal year ending January 3, 2026, and approving the company’s executive compensation. These decisions reflect the company’s ongoing commitment to maintaining strong governance and financial oversight, which could impact its operational efficiency and stakeholder confidence.